Aug 2026· Handbook of Experimental Pharmacology· 0 citations
Medicine
TL;DR
Overall, the existing findings support TAAR1 as a therapeutic target for treatment of substance use disorders, however, translating these findings into effective human pharmacotherapies requires navigating ligand-specific effects and pharmacokinetic demands and defining the role of human TAAR1 genetic diversity in therapeutic response.
Evidence is provided regarding the impact of trace amine-associated receptor 1 (TAAR1) agonists on rodent models of substance use disorders (SUDs) and a lack of studies examining the effects of TAAR1 agonists in female subjects to strengthen evidence for TAAR1 agonists as potential therapeutic agents for cocaine-use di...
Barathi Bahavan, J. Ruda-Kucerova· Current Neuropharmacology· 0 citations
Results demonstrate that HIV-1 viral protein expression was associated with impaired acquisition of cerebellum-dependent motor learning in a sex-dependent manner and identify sex-specific eCB signaling as a critical factor associated with the neurobiological response to HIV-1 proteins and provide a biological framework...
Barkha J. Yadav-Samudrala, Laith E. Sawaqed, Caitlin J. Huguely Wilkinson et al.· Brain Research Bulletin· 0 citations
Findings identify GPR151 as a conserved, regionally enriched regulator of behavioral sensitivity to inflammatory challenge and support GPR151 as a candidate therapeutic target for inflammation-associated depression.
Lupita Rios, You-Hsin Lin, Laura Yuan et al.· bioRxiv· 0 citations
These findings provide new insights into the distinct neurocircuit changes associated with the antipsychotic-like effects of TAAR1 agonists, distinguishing them from D2 receptor-targeting treatments.
Shan Huang, S. M. Yang, Ludovic Bellier et al.· Molecular Psychiatry· 0 citations
It is demonstrated that S1R is involved in METH-induced behavioral sensitization and that SOMCL-668 could be a potential therapeutic agent for drug addiction.
Qian Yang, Jia-Hui Xiao, Jia-Yuan Li et al.· Acta Pharmacologica Sinica· 0 citations
It is indicated that elunetirom and LL- 340001 engage complementary neuroplasticity and mitochondrial biogenesis-related programs in neuronal systems and support further investigation of brain-targeted thyromimetic signaling as a mechanistically differentiated approach for major depressive disorder and bipolar depressi...
Jason R. Harris, Jill Baccei, W. Stratton et al.· bioRxiv· 0 citations
Zero-knowledge proofs can verify computing results without rerunning workloads or exposing sensitive data. Magnetar helps bring them into the mainstream with support for standard programming languages, major speed gains, and quantum-resistant security. The post Proof-based general-purpose computing with Magnetar appeared first on Microsoft Research.